Merus NV Sustainability Reports
Merus NV is a biopharmaceutical company specializing in the development of innovative bispecific antibody therapies for the treatment of cancer.
Sector: Health Care
Country: Netherlands
Exchange: Nasdaq Stock Market
ISIN: NL0011606264
2 reports from 2020 to 2024
Company Profile
Merus NV
Merus NV is a biopharmaceutical company specializing in the development of innovative bispecific antibody therapies for the treatment of cancer.
Reports